tiprankstipranks
Eli Lilly & Co Appoints Procter & Gamble CEO to Board
Company Announcements

Eli Lilly & Co Appoints Procter & Gamble CEO to Board

Don't Miss our Black Friday Offers:

An update from Eli Lilly & Co ( (LLY) ) is now available.

Eli Lilly and Company announced the appointment of Jon Moeller, Chairman and CEO of Procter & Gamble, to its board of directors, effective December 1, 2024. Moeller brings extensive experience in leadership and strategic operations, complementing Lilly’s focus on innovation and growth. Concurrently, board member Karen Walker will resign at the end of 2024 but will continue collaborating with Lilly on digital initiatives in 2025. This transition marks a strategic evolution for Lilly as it enhances its digital and commercial capabilities.

For detailed information about LLY stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyEli Lilly and China-based biotech Laekna team on obesity drug
TheFlyOppenheimer biotech analyst holds an analyst/industry conference call
TheFlyEli Lilly, Verge announce milestones in ALS collaboration
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App